Physician profile
William Stoutt
NPI 1750777397
$7,261.92
in general payments reported to CMS, 2019-2025
12 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.90 · 2021: $925 · 2022: $1,129 · 2023: $97.84 · 2024: $4,758 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,674 · Food and Beverage: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,674.10 |
| Food and Beverage | $1,510.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,619.93 | 2021-2024 | Optis, Ensite, Mitraclip |
| Ge Healthcare | $1,547.36 | 2024 | |
| Abiomed | $954.44 | 2022-2025 | Impella |
| Medtronic, INC. | $409.40 | 2021-2024 | Attain Command + Surevalve |
| Boston Scientific Corporation | $348.83 | 2021 | |
| Biotronik INC. | $135.88 | 2022 | |
| Philips North America LLC | $124.19 | 2021 | |
| Teleflex LLC | $35.80 | 2023 | Vascband |
| Shockwave Medical, INC | $31.70 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.03 | 2024 | |
| Terumo Medical Corporation | $14.46 | 2024 | Glidewire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stoutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.